Francois Brisebois
Stock Analyst at Oppenheimer
(1.04)
# 3,663
Out of 4,876 analysts
89
Total ratings
28.41%
Success rate
-15.11%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Maintains: Outperform | $70 → $80 | $8.68 | +821.66% | 2 | Mar 28, 2025 | |
| ABEO Abeona Therapeutics | Initiates: Outperform | $16 | $5.75 | +178.26% | 1 | Mar 5, 2025 | |
| OVID Ovid Therapeutics | Upgrades: Outperform | $4 | $0.30 | +1,224.50% | 1 | Jan 29, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Outperform | $65 → $72 | $40.32 | +78.57% | 7 | Jan 22, 2025 | |
| MNMD Mind Medicine (MindMed) | Reiterates: Outperform | $20 | $6.54 | +205.81% | 4 | Dec 17, 2024 | |
| TRDA Entrada Therapeutics | Maintains: Outperform | $25 → $28 | $6.93 | +304.04% | 2 | Nov 6, 2024 | |
| AVDL Avadel Pharmaceuticals | Maintains: Outperform | $29 → $30 | $9.20 | +226.09% | 8 | Oct 31, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $143 → $163 | $43.01 | +278.98% | 4 | Oct 31, 2024 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Outperform | $56 → $59 | $31.98 | +84.49% | 5 | Oct 30, 2024 | |
| DYN Dyne Therapeutics | Reiterates: Outperform | $55 | $9.57 | +474.71% | 5 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $15 | $4.62 | +224.68% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $6 | $3.83 | +56.66% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $11 | $2.23 | +393.27% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $13.20 | +6.06% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $15 | $2.20 | +581.82% | 4 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $2.33 | +975.27% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $65 | $16.86 | +285.53% | 5 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $3.79 | +164.20% | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $5 | $0.61 | +719.67% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $152 | $8.15 | +1,765.03% | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $63 → $36 | $19.28 | +86.72% | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $5 → $4 | $3.80 | +5.26% | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $60 | $0.20 | +30,481.04% | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7,200 → $5,400 | $3.29 | +164,033.74% | 2 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8.5 | $3.25 | +161.94% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $11 | $4.09 | +168.95% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $18 | $2.29 | +686.03% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $2.77 | +1,705.05% | 1 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,240 | $1.81 | +178,905.52% | 1 | Feb 4, 2020 |
Sensei Biotherapeutics
Mar 28, 2025
Maintains: Outperform
Price Target: $70 → $80
Current: $8.68
Upside: +821.66%
Abeona Therapeutics
Mar 5, 2025
Initiates: Outperform
Price Target: $16
Current: $5.75
Upside: +178.26%
Ovid Therapeutics
Jan 29, 2025
Upgrades: Outperform
Price Target: $4
Current: $0.30
Upside: +1,224.50%
Tarsus Pharmaceuticals
Jan 22, 2025
Maintains: Outperform
Price Target: $65 → $72
Current: $40.32
Upside: +78.57%
Mind Medicine (MindMed)
Dec 17, 2024
Reiterates: Outperform
Price Target: $20
Current: $6.54
Upside: +205.81%
Entrada Therapeutics
Nov 6, 2024
Maintains: Outperform
Price Target: $25 → $28
Current: $6.93
Upside: +304.04%
Avadel Pharmaceuticals
Oct 31, 2024
Maintains: Outperform
Price Target: $29 → $30
Current: $9.20
Upside: +226.09%
Praxis Precision Medicines
Oct 31, 2024
Maintains: Outperform
Price Target: $143 → $163
Current: $43.01
Upside: +278.98%
Harmony Biosciences Holdings
Oct 30, 2024
Reiterates: Outperform
Price Target: $56 → $59
Current: $31.98
Upside: +84.49%
Dyne Therapeutics
Sep 3, 2024
Reiterates: Outperform
Price Target: $55
Current: $9.57
Upside: +474.71%
Aug 19, 2024
Reiterates: Outperform
Price Target: $15
Current: $4.62
Upside: +224.68%
Aug 16, 2024
Reiterates: Outperform
Price Target: $6
Current: $3.83
Upside: +56.66%
Aug 15, 2024
Reiterates: Outperform
Price Target: $11
Current: $2.23
Upside: +393.27%
Aug 14, 2024
Reiterates: Outperform
Price Target: $14
Current: $13.20
Upside: +6.06%
Jun 26, 2024
Maintains: Outperform
Price Target: $11 → $15
Current: $2.20
Upside: +581.82%
Jun 25, 2024
Initiates: Outperform
Price Target: $25
Current: $2.33
Upside: +975.27%
Jun 13, 2024
Maintains: Outperform
Price Target: $55 → $65
Current: $16.86
Upside: +285.53%
May 6, 2024
Reiterates: Outperform
Price Target: $10
Current: $3.79
Upside: +164.20%
Apr 1, 2024
Reiterates: Outperform
Price Target: $5
Current: $0.61
Upside: +719.67%
Aug 30, 2023
Reiterates: Outperform
Price Target: $152
Current: $8.15
Upside: +1,765.03%
Aug 17, 2023
Maintains: Outperform
Price Target: $63 → $36
Current: $19.28
Upside: +86.72%
Apr 4, 2023
Maintains: Outperform
Price Target: $5 → $4
Current: $3.80
Upside: +5.26%
Apr 3, 2023
Maintains: Outperform
Price Target: $100 → $60
Current: $0.20
Upside: +30,481.04%
Feb 6, 2023
Maintains: Outperform
Price Target: $7,200 → $5,400
Current: $3.29
Upside: +164,033.74%
Sep 7, 2022
Initiates: Outperform
Price Target: $8.5
Current: $3.25
Upside: +161.94%
Aug 29, 2022
Maintains: Outperform
Price Target: $17 → $11
Current: $4.09
Upside: +168.95%
Jul 18, 2022
Assumes: Outperform
Price Target: $18
Current: $2.29
Upside: +686.03%
Oct 29, 2021
Initiates: Outperform
Price Target: $50
Current: $2.77
Upside: +1,705.05%
Feb 4, 2020
Initiates: Buy
Price Target: $3,240
Current: $1.81
Upside: +178,905.52%